A study comparing different approaches in managing neck nodes in early carcinoma of the tongue
- PMID: 12506293
A study comparing different approaches in managing neck nodes in early carcinoma of the tongue
Abstract
Objective: To evaluate elective neck treatment in patients with early stage (T1-2 negative neck node [N0]) squamous cell carcinoma of the oral tongue.
Methods: The medical records of all patients with early stage (T1-2 N0) of oral tongue cancer at the King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia, between January 1980 and December 1997, were identified and retrospectively reviewed.
Results: Our cohort consisted of 93 patients: 45 males and 48 females, with a median age of 60 years. All patients received treatment with curative intent. Partial glossectomy was carried out, except for 8 patients who underwent tongue brachytherapy. The neck was observed in 29 patients, 36 were treated by modified neck dissection, and 28 by elective neck irradiation. With a median follow-up of 62 months, 29 patients had documented neck node recurrence. Ninety six percent (28/29) of recurrences occurred within 22 months from treatment completion. The 5 year actuarial event free survival with regard to nodal relapse in observed was 59%, dissected was 79% and irradiated neck was 63%. Our results showed a trend toward better neck node control in patients managed by elective neck dissection compared to those observed (p=0.07) or receiving elective neck irradiation (p=0.18). Tumor thickness of more than 10 mm was associated with increased risk of nodal relapse (p=0.0004). Neck node recurrence has a poor prognosis with a 5 year disease specific survival of 16%.
Conclusion: A trend for higher neck control was observed after neck dissection in patients with T1-2 N0 squamous cell carcinoma of the oral tongue. Elective neck dissection should be considered particularly for patients with tumor thickness of more than 10 mm.
Similar articles
-
[Squamous-cell carcinoma of the tongue: treatment results and prognosis].Rev Stomatol Chir Maxillofac. 2003 Feb;104(1):10-7. Rev Stomatol Chir Maxillofac. 2003. PMID: 12644785 French.
-
Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.Laryngoscope. 2006 Mar;116(3):461-5. doi: 10.1097/01.mlg.0000195366.91395.9b. Laryngoscope. 2006. PMID: 16540910
-
Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients?ANZ J Surg. 2005 Mar;75(3):101-5. doi: 10.1111/j.1445-2197.2005.03306.x. ANZ J Surg. 2005. PMID: 15777383
-
[Radiotherapy in the treatment of carcinomas of the base of the tongue. Analysis of the literature and personal experience].Radiol Med. 1988 Apr;75(4):370-5. Radiol Med. 1988. PMID: 3287497 Review. Italian.
-
[Peroperative radiotherapy and cancer of the base of tongue. Technic, indications and preliminary results].Ann Otolaryngol Chir Cervicofac. 1989;106(8):561-5. Ann Otolaryngol Chir Cervicofac. 1989. PMID: 2694894 Review. French.
Cited by
-
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.J Clin Oncol. 2019 Jul 10;37(20):1753-1774. doi: 10.1200/JCO.18.01921. Epub 2019 Feb 27. J Clin Oncol. 2019. PMID: 30811281 Free PMC article.
-
The occult nodal metastasis rate of early tongue cancer (T1-T2): A protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2021 Jan 22;100(3):e24327. doi: 10.1097/MD.0000000000024327. Medicine (Baltimore). 2021. PMID: 33546063 Free PMC article.
-
Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis.Head Neck. 2022 Jun;44(6):1481-1491. doi: 10.1002/hed.27022. Epub 2022 Feb 28. Head Neck. 2022. PMID: 35229398 Free PMC article.